|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM157663930 |
| 003 |
DE-627 |
| 005 |
20250206163603.0 |
| 007 |
tu |
| 008 |
231223s2006 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed25n0526.xml
|
| 035 |
|
|
|a (DE-627)NLM157663930
|
| 035 |
|
|
|a (NLM)16150646
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Moens, Leen
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Fcgamma-receptor IIA genotype and invasive pneumococcal infection
|
| 264 |
|
1 |
|c 2006
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 03.03.2006
|
| 500 |
|
|
|a Date Revised 07.12.2022
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Streptococcus pneumoniae is a major cause of pneumonia, bacteraemia, meningitis, and acute otitis media, especially in young children, immunocompromised patients, and elderly. Fcgamma-IIA receptor plays a crucial role in the phagocytosis of IgG2-opsonized bacteria since it is the sole receptor able to interact with IgG2 antibodies. Fcgamma-RIIA exhibits allelic polymorphisms with different capacities for binding IgG2 and phagocytosis. In a prospective study, we genotyped Fcgamma-RIIA in 55 Caucasian patients suffering from invasive pneumococcal disease and in 100 Caucasian controls. In contrast to previous reports, we found no association between Fcgamma-RIIA genotype and invasive pneumococcal disease
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Antigens, CD
|2 NLM
|
| 650 |
|
7 |
|a Fc gamma receptor IIA
|2 NLM
|
| 650 |
|
7 |
|a Receptors, IgG
|2 NLM
|
| 700 |
1 |
|
|a Van Hoeyveld, Erna
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Verhaegen, Jan
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a De Boeck, Kris
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Peetermans, Willy E
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Bossuyt, Xavier
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 118(2006), 1 vom: 01. Jan., Seite 20-3
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnas
|
| 773 |
1 |
8 |
|g volume:118
|g year:2006
|g number:1
|g day:01
|g month:01
|g pages:20-3
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 118
|j 2006
|e 1
|b 01
|c 01
|h 20-3
|